OPX Biotechnologies Raises $17.5 Million
Published: Apr 07, 2009
Private Equity Hub -- OPX Biotechnologies Inc., a Boulder, Colo.-based company focused on improving the viability and cost-effectiveness of biofuels and biorefined chemicals, has raised $17.5 million in Series C funding. Braemar Energy Ventures led the round, and was joined by Altira Group and return backers Mohr Davidow Ventures and X/Seed Capital. peHUB had previously reported on the round, based on a regulatory filing.